Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7413

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907413)

Rosuvastatin Calcium 40 mg film-coated tablets packaging label by A-S Medication Solutions. The label indicates each film-coated tablet contains 41.6 mg rosuvastatin calcium USP equivalent to 40 mg rosuvastatin. The package includes 30 tablets and provides storage instructions to protect from moisture and store at 68 to 77 degrees Fahrenheit. The label also displays the product and lot numbers.*

FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

A cumulative incidence line graph comparing Rosuvastatin Calcium (Rosuva) versus placebo over approximately 5 years. The y-axis represents cumulative incidence in percentage, and the x-axis represents years. Two lines show incidence trends, with Rosuvastatin indicated by a solid line and placebo by a dashed line, demonstrating lower cumulative incidence for Rosuvastatin throughout the period. The chart includes number at risk data at several intervals for both groups.*

FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

A data table comparing the number of cardiovascular and related events in patients treated with Rosuvastatin Calcium 20 mg versus placebo at 20 mg, including event counts, rates per 1000 patient years, hazard ratios with 95% confidence intervals, and P values. The data includes primary endpoint major cardiovascular events (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization, with an accompanying hazard ratio plot.*

FDA Label Image

Figure 3. (Rosuvastatin Fig3)

A box plot chart depicting the percent change from baseline in LDL-C levels for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. Each statin is shown at multiple dose levels (10, 20, 40 mg for all; Atorvastatin and Simvastatin also include 80 mg). The vertical axis represents percent change ranging from 0 to -75%. The chart shows distributions of LDL-C percent change for each dose and statin.*

FDA Label Image

Chemical Structure (Rosuvastatin Str)

Chemical structure of Rosuvastatin Calcium showing its molecular components including fluorophenyl group, pyrimidine ring, sulfonamide group, hydroxyl groups, carboxylate group, and calcium ion with 2+ charge.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.